Aroa Biosurgery Ltd
ASX:ARX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Stemmer Imaging AG
XETRA:S9I
|
DE |
|
Amphenol Corp
NYSE:APH
|
US |
Aroa Biosurgery Ltd
Other Equity
Aroa Biosurgery Ltd
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Aroa Biosurgery Ltd
ASX:ARX
|
Other Equity
-NZ$344k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Pacific Edge Ltd
NZX:PEB
|
Other Equity
NZ$907k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
|
Aroa Biosurgery Ltd
Glance View
Aroa Biosurgery Ltd. engages in the development of products for wound care and soft tissue regeneration. The firm is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. The company designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.
See Also
What is Aroa Biosurgery Ltd's Other Equity?
Other Equity
-344k
NZD
Based on the financial report for Mar 31, 2025, Aroa Biosurgery Ltd's Other Equity amounts to -344k NZD.
What is Aroa Biosurgery Ltd's Other Equity growth rate?
Other Equity CAGR 5Y
-21%
Over the last year, the Other Equity growth was 49%. The average annual Other Equity growth rates for Aroa Biosurgery Ltd have been -23% over the past three years , -21% over the past five years .
